Effects of sodium glucose cotransporter-2 inhibitors on circulating stem and progenitor cells in patients with type 2 diabetes

被引：0
|
作者：
Bonora, B. [1 ]
Cappellari, R. [1 ]
Avogaro, A. [1 ]
Fadini, G. [1 ]
机构：
[1] Univ Padua, Padua, Italy
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
649
引用
收藏
页码：S315 / S315
页数：1
相关论文
共 50 条
  • [31] Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Weight in Type 2 Diabetes Mellitus and Therapeutic Regimen Recommendation
    Wang, Dong-Dong
    Mao, Yi-Zhen
    Yang, Yang
    Wang, Tian-Yun
    Zhu, Ping
    He, Su-Mei
    Chen, Xiao
    JOURNAL OF DIABETES RESEARCH, 2022, 2022
  • [32] Effects of Sodium-Glucose Cotransporter-2 Inhibitors on the Risk of Atrial Fibrillation in Older Adults with Type 2 Diabetes
    Li, Yujia
    Guo, Yi
    Kimmel, Stephen
    Bian, Jiang
    Schatz, Desmond
    Guo, Jingchuan
    DIABETES, 2023, 72
  • [33] Hypothetical intervention of sodium-glucose cotransporter-2 inhibitors on renal outcome in type 2 diabetes
    Takeuchi, Masato
    Kawakami, Koji
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 131 - 132
  • [34] Sodium-glucose cotransporter-2 inhibitors and genital and urinary tract infections in type 2 diabetes
    Arakaki, Richard F.
    POSTGRADUATE MEDICINE, 2016, 128 (04) : 409 - 417
  • [35] The Effects of Insulin Treatment on Circulating Ketone Levels in Patients with Type 2 Diabetes on Sodium-Glucose Cotransporter 2 Inhibitors
    Lee, Chi Ho
    Lam, Joanne K.
    Lee, Alan C.
    Lui, David T. W.
    Fong, Ho Yi Carol
    Woo, Yu Cho
    Lam, Karen S.
    Tan, Kathryn C.
    DIABETES, 2019, 68
  • [36] Decreased risk of renal cell carcinoma in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors
    Chiu, Chun-Huei
    Wang, Wei-Yao
    Chen, Hung-Yi
    Liao, Pei-Lun
    Jong, Gwo-Ping
    Yang, Tsung-Yuan
    CANCER SCIENCE, 2024, 115 (06) : 2059 - 2066
  • [37] Should sodium-glucose cotransporter-2 inhibitors be first-line treatment for patients with type 2 diabetes?
    van Walraven, Carl
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2020, 192 (14) : E375 - E376
  • [38] Cardiovascular Disease Management With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Cardiology Primer
    Zhang, Allan
    Kalil, Ramsey
    Marzec, Alexander
    Coulter, Stephanie A.
    Virani, Salim
    Patel, Kershaw V.
    Segar, Matthew W.
    TEXAS HEART INSTITUTE JOURNAL, 2024, 51 (01)
  • [39] The Clinical Efficacy and Safety of Sodium Glucose Cotransporter-2 Inhibitors in Adults with Type 2 Diabetes Mellitus
    Taylor, Shawn Riser
    Harris, Kira B.
    PHARMACOTHERAPY, 2013, 33 (09): : 984 - 999
  • [40] Obesity as a modifier of the cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes
    Suissa, Karine
    Schneeweiss, Sebastian
    Douros, Antonios
    Yin, Hui
    Patorno, Elisabetta
    Azoulay, Laurent
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 192
12345